Broken String
Novel genome editing technologies
Broken String has raised €14M across 1 funding round from 5 investors, most recently a Series A round in Sep 2023. Based in Cambridge, UK; active in Healthtech. Data as of 4 Nov 2026.
Cambridge, UKwww.brokenstringbio.com ↗
Total raised
€14M
€14,067,336
Funding rounds
1
Investors
5
distinct backers
Active since
2023-09
latest 2023-09
Funding by year
EUR raised per yearBroken String — funding by year — interactive chart.
Data table
| Broken String — funding by year | |
|---|---|
| 2023 | €14M |
Signals
High confidenceRaise-next likelihood10
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-18 | Series A | €14M | Dieter von Holtzbrinck Ventures (DvH Ventures),Heran Partners,Illumina Ventures,Mérieux Equity Partners,Tencent | View deal → |
Investors
5Related news
Similar companies
same sector, similar size- Inflow€13MUK · Healthtech
- Feel€15MUK · Healthtech
- Optellum€16MUK · Healthtech
- Jellagen€12MUK · Healthtech
- Little Journey€12MUK · Healthtech
- Leucid Bio€14MUK · Healthtech
Global coverage: FundingData